Is Lithium Still Worth Using? An update of selected recent research
Baldessarini RJ, Tondo L, Hennen J, Viguera AC.
Department of Psychiatry, Harvard Medical School, Boston, Mass.
The treatment of bipolar disorder has seen greater innovation in the past
decade than at any other time since the introduction of
lithium and the
neuroleptics a half-century ago. The place of lithium in contemporary
psychiatric therapeutics has become controversial, calling for the present
overview of research findings pertaining to its use in treating patients
with bipolar disorder.
Lithium, by itself, typically is inadequate for rapid control of acute
mania;
antipsychotics, divalproex, or potent sedatives are
commonly used, with or without lithium, for this purpose. The special
usefulness of lithium lies in long-term prevention of recurrences of mania
and bipolar depression and in
reducing risk of suicidal behavior. Lithium
also may be beneficial in recurrent unipolar depression and is an effective
adjunct for treatment-resistant depression.
Expectations that
prolonged untreated bipolar illness, multiple episodes,
rapid cycling, or retreatment
following discontinuation might routinely lead to lithium nonresponsiveness,
and the belief that lithium is too toxic for use during pregnancy, have not
been borne out by research. Lithium retains a substantial share of
prescriptions for bipolar disorder and is inexpensive. No other treatment
has performed as well as lithium in as many aspects of long-term care of
bipolar disorder patients, and despite some risks and limitations, lithium
remains the standard against which all proposed alternatives are compared.
Source: Harv Rev Psychiatry. 2002 Mar-Apr;10(2):59-75.
top ~
next ~
send page to a
friend |